Quarterly Results

  • Company Name :
Alivus Life Sciences Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 543322
  • NSE Symbol:
  • ALIVUS
  • P/E(TTM):
  • 20.59
  • ISIN Demat:
  • INE03Q201024
  • Div & Yield%:
  • 0.53
  • EPS(TTM):
  • 45.82
  • Book Value(₹):
  • 245.68
  • Market Cap(₹Cr.):
  • 11,580.17
  • Face Value(₹):
  • 2.00
Quarters :  
Particulars December 2025 ( Cr)September 2025 ( Cr)June 2025 ( Cr)
Gross Sales 672.89 587.98 601.85
Excise Duty 0.00 0.00 0.00
Net Sales 672.89 587.98 601.85
Other Operating Income 0.00 0.00 0.00
Other Income 13.93 14.72 8.99
Total Income 686.82 602.70 610.83
Total Expenditure 467.27 408.81 429.54
PBIDT 219.54 193.89 181.30
Interest 1.49 1.32 1.25
PBDT 218.05 192.57 180.05
Depreciation 19.66 18.44 17.06
Tax 53.92 39.95 38.94
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -5.79 4.16 2.51
Reported Profit After Tax 150.26 130.03 121.54
Extra-ordinary Items -18.68 0.00 0.00
Adjusted Profit After Extra-ordinary item 168.94 130.03 121.54
EPS (Unit Curr.) 12.25 10.60 9.91
EPS (Adj) (Unit Curr.) 12.25 10.60 9.91
Calculated EPS (Unit Curr.) 12.25 10.22 9.91
Calculated EPS (Adj) (Unit Curr.) 12.25 10.22 9.91
Calculated EPS (Ann.) (Unit Curr.) 48.99 40.90 39.64
Calculated EPS (Adj) (Ann.) (Unit Curr.) 48.99 40.90 39.64
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 24.54 25.44 24.53
Reserve & Surplus 0.00 0.00 0.00
Face Value 2.00 2.00 2.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 32.63 32.98 30.12
PBDTM(%) 32.40 32.75 29.92
PATM(%) 22.33 22.11 20.19